1[1]Cunha BA. Pneumonias in the compromised host. Infect Dis Clin Nor Am,2001,15(2) :591.
2[2]Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis,1999,29(2) :253.
3[3]Munoz P, Burillo A , Bouza E, et al. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit.Int J Antimicrob Agents,2000,15(2) :83.
4[4]Marik PE. Fever in the ICU. Chest,2000,117(3) :855.
5[5]Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J,2000,19(4) :319.
6[6]Chen KY, Ko SC, Hsueh PR, et al. Pulmonary fungal infection:emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest, 2001,120(1):177.
7[7]Klein NC, Go CH, Cunha BA. Infections associated with steroid use. Infect Dis Clin North Am,2001,15(2):423.
8[8]BenjaminDK Jr, RossK, McKinney RE Jr, etal. When to suspect fungal infection in neonates: A clinical comparison of Candida albicars and Candida parapsilosis fungemia with coagulase-negativestaphylococcal bacteremia. Pediatrics,2000,106(4) :712.
9[9]Jamal WY, El-Din K, Rotimi VO, et al. An analysis of hospital-acquired bacteremia in intensive care unit patients in a university hospital in Kuwait. J Hosp Infect, 1999,43(1 ) :49.
10[10]Vincent JL, Anaissie E, Bruining H, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med, 1998,24(3) :206.
